University of Copenhagen, Copenhagen, Denmark; Center of Research & Disruption of Infectious Diseases (CREDID), Department of Infectious Diseases, Copenhagen University Hospital - Amager and Hvidovre, Denmark.
Center of Research & Disruption of Infectious Diseases (CREDID), Department of Infectious Diseases, Copenhagen University Hospital - Amager and Hvidovre, Denmark.
Int J Infect Dis. 2022 Feb;115:1-7. doi: 10.1016/j.ijid.2021.11.021. Epub 2021 Nov 18.
Streptococcus pneumoniae is one of the most important causes of diseases leading to child mortality, especially in low- and lower-middle-income countries. This review aims to describe the prevalence of carriage of S. pneumoniae and the impact of vaccination among children aged under five years in low- and lower-middle-income countries since 2012.
The study is a systematic review of the literature. Relevant publications were searched in PubMed and screened systematically for information on the prevalence of carriage of S. pneumoniae among children aged under five years. 149 publications were identified, and 20 were included in the review.
The prevalence of S. pneumoniae ranged between 26.7% - 90.7%. The prevalence of vaccine-type carriage ranged between 4.4% - 57.6% but generally decreased in countries after the introduction of PCV, with a reduction of 15.6% - 65.7%. Half of the post- pneumococcal conjugate vaccine (PCV) studies reported a vaccine-type carriage rate below 15%.
Vaccine-type-carriage has decreased in most countries with the introduction of PCV. Still, coverage is only moderate, and carriage rates of S. pneumoniae vary significantly between countries. Continuous monitoring of carriage is needed to evaluate the effect of the further introduction of PCV10 and PCV13.
肺炎链球菌是导致儿童死亡的重要病因之一,尤其是在低收入和中低收入国家。本综述旨在描述 2012 年以来,低收入和中低收入国家 5 岁以下儿童中肺炎链球菌携带率及疫苗接种的影响。
本研究为文献系统综述。在 PubMed 中搜索相关文献,并对 5 岁以下儿童肺炎链球菌携带率的信息进行系统筛选。共确定了 149 篇出版物,其中 20 篇被纳入综述。
肺炎链球菌携带率在 26.7%-90.7%之间。疫苗型携带率在 4.4%-57.6%之间,但在 PCV 引入后,大多数国家的携带率均下降,降幅为 15.6%-65.7%。半数肺炎球菌结合疫苗(PCV)后研究报告疫苗型携带率低于 15%。
PCV 引入后,大多数国家的疫苗型携带率有所下降。但覆盖率仍处于中等水平,且各国间肺炎链球菌携带率差异显著。需要持续监测携带率,以评估进一步引入 PCV10 和 PCV13 的效果。